Bambang Irawan SpPD [K], SpJP [K], FIHA, FASCC, FINASIM Internist [SpPD] 1981 Cardiovascular Consultant [KKV] 1996 Cardiologist [SpJP] 2004 Fellow of Indonsian Heart Association[FIHA] 2004 Cardiologist Consultant [ K ] 2005 Professor in Cardiology [ Prof ] 2006 Fellow of Asean College Cardiology[FASCC] 2008 Fellow of Ind Society of Internal Medicine 2009
24
Embed
Neurohumoral Activation Treatment Approach in Heart Failure
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Bambang Irawan SpPD [K], SpJP [K],
FIHA, FASCC, FINASIM
Internist [SpPD] 1981
Cardiovascular Consultant [KKV] 1996
Cardiologist [SpJP] 2004
Fellow of Indonsian Heart Association[FIHA] 2004
Cardiologist Consultant [ K ] 2005
Professor in Cardiology [ Prof ] 2006
Fellow of Asean College Cardiology[FASCC] 2008
Fellow of Ind Society of Internal Medicine 2009
NEUROHUMORAL ACTIVATION
& THERAPEUTIC APPROACH
IN HEART FAILURE
BAMBANG IRAWAN MD FIHA FASCC FINASIM
Professor in Cardiology and Vascular Medicine
Departement of Cardiology, Faculty of Medicine,
Gadjah Mada University Yogyakarta
PREVENTING & THERAPEUTIC IN HEART
FAILURE
HEART FAILURE IS A COMMON DISEASE
HEART FAILURE IS DISEASE WITH A HIGH
MORBIDITY & MORTALITY
ASSOCIATED WITH HIGH COST BOTH THE PATIENTS
& HEALTH-CARE SYSTEMS
65 YEARS AGO, BEFORE ANTIHYPERTENSION DRUG,
HEART FAILURE WAS THE MOST COMMON
COMPLICATIONS OF HYPERTENSION
FRAMINGHAM [1971] DEMONSTRATED THAT
HYPERTENSION WAS THE MAJOR FACTOR IN
CAUSED OF HEART FAILURE
MAJOR RISK FACTOR FOR THE
DEVELOPMENT OF HEART FAILURE
HYPERTENSION
MYOCARDIAL INFARCTION
ANGINA PECTORIS
DIABETES
LEFT VENTRICULAR HYPERTROPHY
VALVULAR DISEASE
HEART FAILURE & DIABETES
HEART FAILURE 2X COMMON IN DIABETIC MAN & 5X IN DIABETIC WOMEN
12% TYPE 2 DIABETICS BECOME HEART FAILURE
EACH YEAR 3.3% TYPE 2 DIABETICS BECOME HEART FAILURE
Bell Diabetes Care 2003Amato et al Diabetes Metab 1997